A
Allonnia
Waste exploring biology-based waste management solutions
About Allonnia
Allonnia is a bio-ingenuity company that specializes in transforming waste into value. The company operates in the environmental sector, focusing on finding innovative solutions to major environmental problems using microorganisms. Allonnia's business model is a blend of science, engineering, and environmentalism, leveraging deep biological expertise and cutting-edge technology to create transformative solutions.
Read full description
The company serves clients in markets where it can make a significant impact, particularly in the treatment of contaminated water and the production of more efficient, biological solutions. Allonnia's primary offerings include technologies that remove harmful chemicals like PFAS and 1,4-dioxane from water and a system that enhances the capabilities of SAFF (Submerged Aerated Fixed Films) to remove short-chain PFAS in groundwater and landfill leachate.
One of Allonnia's key products is a proprietary microbe that transforms 1,4-dioxane into water and carbon dioxide. This product is delivered through a returnable, portable system, making it a convenient solution for clients. Another product is an award-winning technology that uses rising air bubbles to rapidly separate and concentrate PFAS for destruction.
Allonnia generates revenue by selling these innovative solutions to clients in need of environmental remediation. The company, a spinout of Ginkgo Bioworks, was launched in 2020 and has since extended its Series A funding round.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Boston, United States
- Employees
- 56
- Open positions
- None listed
- Dealroom signal
- 70.8/100
- Sub-industry
- Oil & Gas, Water, Waste Solution
- Sector
- Energy, Mining Technologies, Biotechnology, Water Treatment, Waste Reduction, Sustainable Development Goals, Wastewater Treatment, Climate Tech
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jul 2023 | $30M | $200M | General Atlantic · Battelle Memorial Institute · Viking Global Investors · Bison Ventures | ↗ |
| SERIES AOther financing | Mar 2021 | $20M | $200M | Evok Innovations | — |
Growth signals
Latest recorded traffic for Allonnia is 3.5K monthly website visits, up 20.7% over the last three months. Allonnia's team declined 1.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A11 investors entered at this stage
Viking Global Investors
General Atlantic
Cascade Investment
Battelle Memorial Institute
Evok Innovations
Bison Ventures- PPPPNG
Vale
IRONGREY
BHP Ventures- WLWholestack LP
Series B and later1 investor entered at this stage
Ginkgo Bioworks
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Allonnia on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Allonnia’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.